Steven Filby, MD
Specialty: Cardiology-Interventional Cardiology
- Assistant Professor, CWRU School of Medicine
Steven Filby, MD, is an interventional cardiologist and director of the cardiac catheterization laboratory at University Hospitals Cleveland Medical Center.
Dr. Filby’s practice focuses on the medical and percutaneous treatment of coronary artery disease and structural heart disease. He has advanced training in the minimally invasive repair of congenital and valvular heart abnormalities. With more than 10 years experience, he previously practiced at FirstHealth of the Carolinas in Pinehurst, North Carolina, where he served as director of the transcatheter aortic valve replacement (TAVR) program and chief of cardiology.
Born and raised in New Orleans, Dr. Filby graduated from Harvard University with honors and obtained his medical degree from Louisiana State University School of Medicine in New Orleans. He completed his internal medicine residency at Stanford University Hospital and cardiology fellowship at University of North Carolina Health Care in Chapel Hill. Dr. Filby then completed a two year advanced fellowship in interventional cardiology, peripheral and structural intervention at the Cleveland Clinic. Dr. Filby is board-certified in cardiovascular medicine and interventional cardiology and board- eligible in vascular medicine.
Dr. Filby and his wife, Kimberly, have three daughters. He enjoys running, swimming and reading. Dr. Filby is also an avid beekeeper and a lifelong New Orleans Saints fan. He is a member of the Endymion Carnival Club and participates in the Mardi Gras parades each year.
- Interventional Cardiology - American Board of Internal Medicine
- Cardiovascular Disease - American Board of Internal Medicine
Fellowship | Advanced Interventional and Structural Cardiology
Advanced Interventional and Structural Cardiology - Cleveland Clinic (2008 - 2009)
Fellowship | Interventional Cardiology
Interventional Cardiology - Cleveland Clinic (2007 - 2008)
Fellowship | Cardiovascular Disease
Cardiovascular Disease - University Of North Carolina Health Care (2004 - 2007)
Residency | Internal Medicine
Internal Medicine - Stanford Hospital And Clinics (2001 - 2004)
Louisiana State University School Of Medicine (1997 - 2001)
Harvard University (1995)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Steven Filby did not disclose any Outside Relationships with Industry.